技术概述
无创胚胎植入潜能筛查（Noninvasive Implantation Capability Screening ，NICS®）是指通过NICSInst®专利技术结合第二代高通量测序的方法，检测培养至囊胚期时培养液中游离的DNA，以游离DNA的检测结果来反映整个胚胎的染色体情况，帮助医生在不进行活检的前提下，得到胚胎染色体的筛查结果，作为甄选移植胚胎的参考条件。
无创胚胎植入潜能筛查（Noninvasive Implantation Capability Screening ，NICS®）是指通过NICSInst®专利技术结合第二代高通量测序的方法，检测培养至囊胚期时培养液中游离的DNA，以游离DNA的检测结果来反映整个胚胎的染色体情况，帮助医生在不进行活检的前提下，得到胚胎染色体的筛查结果，作为甄选移植胚胎的参考条件。
Chromosome screening using culture medium of embryosfertilised in vitro a pilot clinicalstudy
Noninvasive chromosome screening of human embryos by genome sequencing of embryo culture medium for in vitro fertilization
Non-invasive pre-implantation aneuploidy screening and diagnosis of beta thalassemia IVSII654 mutation using spent embryo culture medium
Preimplantation Genetic Screening with Spent Culture MediumBlastocoel Fluid for in Vitro Fertilization
Noninvasive preimplantation genetic testing for aneuploidy in spent medium may be more reliable than trophectoderm biopsy
Minimally invasivepreimplantation genetic testing using blastocyst culture medium
Less-invasive chromosome screening of embryos and embryo assessment by genetic studies of DNA in embryo culture medium
Non-invasive preimplantation genetic testing for putative mosaic blastocysts: a pilot study
A Non-invasive Chromosome Screening Strategy for Prioritizing in vitro Fertilization Embryos for Implantation
Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium Sample Collection and Chromosomal Ploidy Analysis
澳门人威尼斯b站公众号
澳门人威尼斯b站小助手咨询微信
Global